Baker Brothers Advisors - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$73,024,000
+5321.2%
635,321
+7269.5%
0.74%
+4282.4%
Q3 2014$1,347,000
+26.7%
8,6210.0%0.02%
+30.8%
Q2 2014$1,063,000
+183.5%
8,621
+138.1%
0.01%
+160.0%
Q1 2014$375,000
+15.0%
3,6210.0%0.01%0.0%
Q4 2013$326,000
+34.7%
3,6210.0%0.01%
+66.7%
Q3 2013$242,000
-92.0%
3,621
-92.1%
0.00%
-95.0%
Q2 2013$3,015,00045,5710.06%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 173,845$7,037,0000.28%
AMUNDI ASSET MANAGEMENT US, INC. 537,900$21,774,0000.09%
NOMURA HOLDINGS INC 127,903$5,175,0000.06%
GOLDMAN SACHS GROUP INC 386,458$15,641,0000.01%
AQR Capital Management 26,000$1,052,0000.01%
GOLDMAN SACHS GROUP INC 100,000$4,047,0000.00%
RATIONAL ADVISORS LLC 288$12,0000.00%
HSBC HOLDINGS PLC 5,448$220,0000.00%
View complete list of SALIX PHARMACEUTICALS INC shareholders